UNSPSC 51351802: Polyestradiol phosphate

This classification denotes a therapeutic estradiol with the molecular formula ((C18H22O3P(C18H22O)n)n(C18H23O4P)n)co, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P14877CDX2, chemically known as 17-beta-estra 1,3,5(10)-triene-3,17-diol, 17-dihydrogen phosphate, homopolymer but generally known as polyestradiol phosphate, which bears US NIH Compound Identifier 66435. European Medicines Agency schedules Polyestradiol phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09973MIG.

UNSPSC 51351802 Polyestradiol phosphate is a Commodity code covering a synthetic estrogen pharmaceutical used in hormone replacement therapy and certain cancer treatments. State and local governments procure this medication through their health departments, correctional facilities, public hospitals, and Medicaid programs to serve eligible populations including incarcerated individuals, low-income patients, and state employees. The drug is typically sourced as a finished pharmaceutical product through existing state contracts, cooperative purchasing agreements, or direct purchasing from licensed pharmaceutical distributors and manufacturers who hold appropriate DEA and state pharmacy licenses. Procurement focuses on securing reliable supply chains, negotiating pricing, and ensuring compliance with state pharmacy regulations and formulary requirements.

The recent opportunities block contains no documented state or local solicitations under this code. Without posted RFPs, RFQs, or ITBs naming polyestradiol phosphate or soliciting pharmaceutical suppliers for this specific agent, current procurement activity under the code cannot be characterized by issuing body, geography, or response timeline. The absence of recent visible activity suggests either that acquisitions occur through standing cooperative purchasing vehicles (such as state pharmaceutical contracts or group purchasing organizations) rather than ad hoc solicitation, or that demand remains sporadic enough that opportunities do not appear in the monitored solicitation channels.